Implants And Joint Replacement Company Stryker Tightens Annual Forecast On 'Positive Procedural Trends'
Portfolio Pulse from Vandana Singh
Stryker Corporation reported Q3 sales of $4.9 billion, up 9.6% Y/Y, beating the consensus of $4.86 billion. The company has tightened its 2023 organic net sales growth forecast to 10%-10.5% from the previous range of 9.5%-10.5%. Adjusted EPS for Q3 was $2.46, up 16% and beating the consensus of $2.43. Despite the positive report, SYK shares are down 3.68% at $265 premarket.
November 03, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stryker Corporation reported better than expected Q3 results and tightened its 2023 sales growth forecast. However, its shares are down 3.68% premarket.
Stryker Corporation reported strong Q3 results and increased its 2023 sales growth forecast, which would typically lead to a positive reaction in the stock market. However, the company's shares are down in premarket trading, indicating that other factors not mentioned in the article may be influencing the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100